OCGN Stock: More Upside for Ocugen, Inc. (NASDAQ:OCGN)? – Marketing Sentinel
Home  »  Business   »  OCGN Stock: More Upside for Ocugen, Inc. (NASDAQ:O...

OCGN Stock: More Upside for Ocugen, Inc. (NASDAQ:OCGN)?

In the last trading session, 58,337,771 Ocugen, Inc. (NASDAQ:OCGN) shares changed hands as the company’s beta touched 4.52. With the company’s per share price at $7.4 changed hands at $0.83 or 0.13% during last session, the market valuation stood at $1.47 Billion. OCGN’s last price was a discount, traded about -153.65% off its 52-week high of $18.77. The share price had its 52-week low at $0.19, which suggests the last value was 97.43% up since then. When we look at Ocugen, Inc.’s average trading volume, we note the 10-day average is 40.71 Million shares, with the 3-month average coming to 66.2 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Analysts gave the Ocugen, Inc. (OCGN) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.7. If we narrow down to specifics, the data shows that none out of 4 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, 3 recommended OCGN as a Hold, 1 felt it is a Buy and none rated the stock as Underweight. Ocugen, Inc.’s EPS for the current quarter is expected to be -$0.03.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Ocugen, Inc. (NASDAQ:OCGN) trade information

Instantly OCGN was in green as seen at the end of in last trading. With action 12.63%, the performance over the past five days has been green. The jump to weekly highs of $7.55- on Monday, Jun 21 added 1.99% to the stock’s daily price. The company’s shares are showing year-to-date upside of 3.04%, with the 5-day performance at 0.21% in the green. However, in the 30-day time frame, Ocugen, Inc. (NASDAQ:OCGN) is -0.15% down. Looking at the short shares, we see there were 42.98 Million shares sold at short interest cover period of 0.65 days.

The consensus price target for the stock as assigned by Wall Street analysts is $6.13, meaning bulls need a downside of -17.16% from its current market value. According to analyst projections, OCGN’s forecast low is $4 with $10 as the target high. To hit the forecast high, the stock’s price needs a +35.14% upsurge from its current level, while the stock would need to tank -45.95% for it to hit the projected low.

Ocugen, Inc. (OCGN) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 70.8%. The 2021 estimates are for Ocugen, Inc. earnings to increase by 79%, but the outlook for the next 5-year period is at 0% per year.

Ocugen, Inc. (NASDAQ:OCGN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 2.49% of Ocugen, Inc. shares while 12.62% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 12.94%. There are 98 institutions holding the Ocugen, Inc. stock share, with Vanguard Group, Inc. (The) the top institutional holder. As of Mar 30, 2021, the company held 4.09% of the shares, roughly 8.1 Million OCGN shares worth $55.03 Million.

State Street Corporation holds the second largest percentage of outstanding shares, with 2.54% or 5.03 Million shares worth $34.18 Million as of Mar 30, 2021.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Among Mutual Funds, the top two as of Mar 30, 2021 were Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. With 5040554 shares estimated at $34.23 Million under it, the former controlled 2.54% of total outstanding shares. On the other hand, SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF held about 2.53% of the shares, roughly 5.01 Million shares worth around $43.72 Million.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam